Monomeric IgE and mast cell development, survival and function

Advances in Experimental Medicine and Biology

Volumn 716, Issue , 2011, Pages 29-46

  Kashiwakura, Jun Ichi ^a   Otani, Iris M ^a   Kawakami, Toshiaki ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPOIETIC CELL KINASE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 3; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN KINASE SYK; ANTIGEN;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ANAPHYLAXIS; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; AUTOCRINE EFFECT; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; IMMUNOGLOBULIN AGGREGATE; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; IN VIVO STUDY; INNATE IMMUNITY; MAST CELL; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS; CELL SURVIVAL; HUMANS; IMMUNOGLOBULIN E; MAST CELLS;

EID: 79960911769     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9533-9_3     Document Type: Review

References (115)

1. Galli SJ, Maurer M, Lantz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol 1999; 11(1):53-59. (Pubitemid 29082337)
2. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997; 77(4):1033-1079. (Pubitemid 27459579)
3. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004; 34(4):520-526. (Pubitemid 38534881)
4. Kawakami T. A crucial door to the mast cell mystery knocked in. J Immunol 2009; 183(11):6861-6862.
5. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6(2):135-142. (Pubitemid 40268194)
6. Wedemeyer J, Tsai M, Galli SJ. Roles of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol 2000; 12(6):624-631.
7. Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol 2008; 8(3):205-217. (Pubitemid 351323292)
8. Geha RS, Jabara HH, Brodeur SR. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 2003;3(9):721-732. (Pubitemid 41070813)
9. Barnes PJ. Anti-IgE therapy in asthma: rationale and therapeutic potential. Int Arch Allergy Immunol 2000; 123(3):196-204.
10. Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 1999; 17:931-972.
11. Cambier JC. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol 1995; 155(7):3281-3285.
12. Parravicini V, Gadina M, Kovarova M et al. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 2002; 3(8):741-748.
13. Turner H, Kinet JP. Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 1999; 402(6760 Suppl):B24-30.
14. Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002; 2(10):773-786. (Pubitemid 37328717)
15. Furuichi K, Rivera J, Isersky C. The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression. Proc Natl Acad Sci USA 1985; 82(5):1522-1525. (Pubitemid 15120575)
16. Hsu C, MacGlashan D, Jr. IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. Immunol Lett 1996; 52(2-3):129-134. (Pubitemid 26336713)
17. Yamaguchi M, Lantz CS, Oettgen HC et al. IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997; 185(4):663-672. (Pubitemid 27098151)
18. Asai K, Kitaura J, Kawakami Y et al. Regulation of mast cell survival by IgE. Immunity 2001; 14(6):791-800. (Pubitemid 32592425)
19. Eshhar Z, Ofarim M, Waks T. Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity. J Immunol 1980; 124(2):775-780. (Pubitemid 10135320)
20. Tanaka S, Takasu Y, Mikura S et al. Antigen-independent induction ofhistamine synthesis by immunoglobulin E in mouse bone marrow-derived mast cells. J Exp Med 2002; 196(2):229-235. (Pubitemid 34787512)
21. Kitaura J, Song J, Tsai M et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci USA 2003; 100(22):12911-12916. (Pubitemid 37339999)
22. Yamada N, Matsushima H, Tagaya Y et al. Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells. J Invest Dermatol 2003; 121(6):1425-1432. (Pubitemid 38005496)
23. Oka T, Hori M, TanakaA et al. IgE alone-induced actin assembly modifies calcium signaling and degranulation in RBL-2H3 mast cells. Am J Physiol Cell Physiol 2004; 286(2):C256-263. (Pubitemid 38146349)
24. Pandey V, Mihara S, Fensome-Green A et al. Monomeric IgE stimulates NFAT translocation into the nucleus, a rise in cytosol Ca2+, degranulation and membrane ruffling in the cultured rat basophilic leukemia-2H3 mast cell line. J Immunol 2004; 172(7):4048-4058. (Pubitemid 38375216)
25. Lam V, KalesnikoffJ, Lee CW et al. IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor. Blood 2003; 102(4):1405-1413. (Pubitemid 36988050)
26. Kitaura J, Kinoshita T, Matsumoto M et al. IgE- and IgE+Ag-mediated mast cell migration in an autocrine/ paracrine fashion. Blood 2005; 105(8):3222-3229.
27. Kalesnikoff J, Huber M, Lam V et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity 2001; 14(6):801-811. (Pubitemid 32592426)
28. Kawakami T, Kitaura J. Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance. J Immunol 2005; 175(7):4167-4173. (Pubitemid 41361947)
29. Kitaura J, Eto K, Kinoshita T et al. Regulation of highly cytokinergic IgE-induced mast cell adhesion by Src, Syk, Tec and protein kinase C family kinases. J Immunol 2005; 174(8):4495-4504.
30. Strober W. Immunology: The expanding T(H)2 universe. Nature 2010; 463(7280):434-435.
31. Packard KA, Khan MM. Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol 2003; 3(7):909-920. (Pubitemid 36700444)
32. Goodarzi K, Goodarzi M, Tager AM et al. Leukotriene B4 and BLT1 control cytotoxic effector T-cell recruitment to inflamed tissues. Nat Immunol 2003; 4(10):965-973. (Pubitemid 37265917)
33. Ott VL, Cambier JC, Kappler J et al. Mast cell-dependent migration of effector CD8+ T-cells through production of leukotriene B4. Nat Immunol 2003; 4(10):974-981. (Pubitemid 37265918)
34. Tager AM, Bromley SK, Medoff BD et al. Leukotriene B4 receptor BLT1 mediates early effector T-cell recruitment. Nat Immunol 2003; 4(10):982-990. (Pubitemid 37265919)
35. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9(4):401-410. (Pubitemid 36305074)
36. Nakajima T, Inagaki N, Tanaka H et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcepsilon receptor I cross-linking: an interspecies comparison. Blood 2002; 100(12):3861-3868. (Pubitemid 35396850)
37. Laffargue M, Calvez R, Finan P et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. Immunity 2002; 16(3):441-451. (Pubitemid 34260921)
38. Jolly PS, Bektas M, Olivera A et al. Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. J Exp Med 2004; 199(7):959-970. (Pubitemid 38481087)
39. Matsuda K, Piliponsky AM, Iikura M et al. Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response. J Allergy Clin Immunol 2005; 116(6):1357-1363. (Pubitemid 41740949)
40. Cruse G, Kaur D, Yang W et al. Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J 2005; 25(5):858-863. (Pubitemid 40667684)
41. Gilchrest H, Cheewatrakoolpong B, Billah M et al. Human cord blood-derived mast cells synthesize and release I-309 in response to IgE. Life Sci 2003; 73(20):2571-2581. (Pubitemid 37088207)
42. Borkowski TA, Jouvin MH, Lin SY et al. Minimal requirements for IgE-mediated regulation of surface Fc epsilon RI. J Immunol 2001; 167(3):1290-1296. (Pubitemid 32703124)
43. Kubo S, Matsuoka K, Taya C et al. Drastic up-regulation of Fcepsilonri on mast cells is induced by IgE binding through stabilization and accumulation of Fcepsilonri on the cell surface. J Immunol 2001; 167(6):3427-3434. (Pubitemid 32852588)
44. Kitaura J, Xiao W, Maeda-Yamamoto M et al. Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production and survival. J Immunol 2004; 173(7):4317-4323. (Pubitemid 39280659)
45. Jayapal M, Tay HK, Reghunathan R et al. Genome-wide gene expression profiling of human mast cells stimulated by IgEorFcepsilonRI- aggregationrevealsacomplexnetwork of genes involved in inflammatory responses. BMC Genomics 2006; 7:210.
46. Yip KH, Huang Y, Waye MM et al. Induction of nitric oxide synthases in primary human cultured mast cells by IgE and proinflammatory cytokines. Int Immunopharmacol 2008; 8(5):764-768.
47. Nevin BJ, Broadley KJ. Nitric oxide in respiratory diseases. Pharmacol Ther 2002; 95(3):259-293. (Pubitemid 35247904)
48. Fischer A, Folkerts G, Geppetti P et al. Mediators of asthma: nitric oxide. Pulm Pharmacol Ther 2002; 15(2):73-81. (Pubitemid 34762144)
49. Watanabe M, Satoh T, Yamamoto Y et al. Overproduction of IgE induces macrophage-derived chemokine (CCL22) secretion from basophils. J Immunol 2008; 181(8):5653-5659.
50. Saffar AS, Alphonse MP, Shan L et al. IgE modulates neutrophil survival in asthma: role of mitochondrial pathway. J Immunol 2007; 178(4):2535-2541. (Pubitemid 46233455)
51. Rowland SL, Depersis CL, Torres RM et al. Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B-cell differentiation. J Exp Med 2010.
52. Kawakami Y, Kitaura J, Yao L et al. A Ras activation pathway dependent on Syk phosphorylation of protein kinase C. Proc Natl Acad Sci USA 2003; 100(16):9470-9475. (Pubitemid 37033952)
53. Blank U, Cyprien B, Martin-Verdeaux S et al. SNAREs and associated regulators in the control of exocytosis in the RBL-2H3 mast cell line. Mol Immunol 2002; 38(16-18):1341-1345. (Pubitemid 35253774)
54. Puri N, Roche PA. Ternary SNARE complexes are enriched in lipid rafts during mast cell exocytosis. Traffic 2006; 7(11):1482-1494. (Pubitemid 44524521)
55. Kashiwakura J, Xiao W, Kitaura J et al. Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype. J Leukoc Biol 2008; 84(2):357-367.
56. Liu FT, Bohn JW, Ferry EL et al. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation and characterization. J Immunol 1980; 124(6):2728-2737. (Pubitemid 10116046)
57. MacDonald SM, Lichtenstein LM, Proud D et al. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol 1987; 139(2):506-512. (Pubitemid 17104052)
58. Schroeder JT, Lichtenstein LM, MacDonald SM. An immunoglobulin E-dependent recombinant histamine-releasing factor induces interleukin-4 secretion from human basophils. J Exp Med 1996; 183(3):1265-1270. (Pubitemid 26113990)
59. Gould HJ, Sutton BJ, Beavil AJ et al. The biology of IGE and the basis of allergic disease. Annu Rev Immunol 2003; 21:579-628. (Pubitemid 37174542)
60. Beaven MA, Metzger H. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol Today 1993; 14(5):222-226. (Pubitemid 23124516)
61. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61(2):203-212.
62. Heldin CH. Dimerization of cell surface receptors in signal transduction. Cell 1995; 80(2):213-223.
63. Field KA, Holowka D, Baird B. Fc epsilon RI-mediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling. Proc Natl Acad Sci USA 1995; 92(20):9201-9205.
64. Field KA, Holowka D, Baird B. Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains. J Biol Chem 1997; 272(7):4276-4280. (Pubitemid 27078498)
65. James LC, Roversi P, TawfikDS. Antibody multispecificity mediated by conformational diversity. Science 2003; 299(5611):1362-1367. (Pubitemid 36254643)
66. Schramm G, Mohrs K, Wodrich M et al. Cutting edge: IPSE/alpha-1, a glycoprotein from Schistosoma mansoni eggs, induces IgE-dependent, antigen-independent IL-4 production by murine basophils in vivo. J Immunol 2007; 178(10):6023-6027. (Pubitemid 46717379)
67. Charles N, Monteiro RC, Benhamou M. p28, a novel IgE receptor-associated protein, is a sensor of receptor occupation by its ligand in mast cells. J Biol Chem 2004; 279(13):12312-12318. (Pubitemid 38445797)
68. Jayawardana ST, Ushio H, Niyonsaba F et al. Monomeric IgE and lipopolysaccharide synergistically prevent mast-cell apoptosis. Biochem Biophys Res Commun 2008; 365(1):137-142. (Pubitemid 350102464)
69. Kohno M, Yamasaki S, Tybulewicz VL et al. Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen. Blood 2005; 105(5):2059-2065. (Pubitemid 40731792)
70. Shelburne CP, McCoy ME, Piekorz R et al. Stat5 expression is critical for mast cell development and survival. Blood 2003; 102(4):1290-1297. (Pubitemid 36988035)
71. Sly LM, Kalesnikoff J, Lam V et al. IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species. J Immunol 2008; 181(6):3850-3860.
72. Yanagida M, Fukamachi H, Ohgami K et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5 and IL-6 on the survival of cultured human mast cells. Blood 1995; 86(10):3705-3714.
73. Oskeritzian CA, Zhao W, Pozez AL et al. Neutralizing endogenous IL-6 renders mast cells of the MCT type from lung, but not the MCTC type from skin and lung, susceptible to human recombinant IL-4-induced apoptosis. J Immunol 2004; 172(1):593-600. (Pubitemid 38020517)
74. Takenaka H, Ushio H, Niyonsaba F et al. Synergistic augmentation of inflammatory cytokine productions from murine mast cells by monomeric IgE and toll-like receptor ligands. Biochem Biophys Res Commun 2010; 391(1):471-476.
75. Yoshikawa H, Nakajima Y, Tasaka K. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J Immunol 1999; 162(10):6162-6170. (Pubitemid 29314978)
76. Yoshikawa H, Nakajima Y, Tasaka K. Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells. J Immunol 2000; 165(11):6262-6269.
77. Alfredsson J, Puthalakath H, Martin H et al. Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation. Cell Death Differ 2005; 12(2):136-144. (Pubitemid 40220644)
78. Rivera J, Gilfillan AM. Molecular regulation of mast cell activation. J Allergy Clin Immunol 2006; 117(6):1214-1225 (Pubitemid 43795719)
79. Malbec O, Malissen M, Isnardi I et al. Linker for activation of T-cells integrates positive and negative signaling in mast cells. J Immunol 2004; 173(8):5086-5094. (Pubitemid 39387791)
80. Nunomura S, Gon Y, Yoshimaru T et al. Role of the FcepsilonRI beta-chain ITAM as a signal regulator for mast cell activation with monomeric IgE. Int Immunol 2005; 17(6):685-694. (Pubitemid 41417966)
81. Kawakami Y, Kitaura J, Hartman SE et al. Regulation of protein kinase CbetaI by two protein-tyrosine kinases, Btk and Syk. Proc Natl Acad Sci USA 2000; 97(13):7423-7428. (Pubitemid 30431479)
82. Liu Y, Furuta K, Teshima R et al. Critical role of protein kinase C betaII in activation of mast cells by monomeric IgE. J Biol Chem 2005; 280(47):38976-38981. (Pubitemid 41713847)
83. Yamasaki S, Saito T. Progress in allergy signal research on mast cells: signal regulation of multiple mast cell responses through FcepsilonRI. J Pharmacol Sci 2008; 106(3):336-340. (Pubitemid 351468584)
84. Sakurai D, Yamasaki S, Arase K et al. Fc epsilon RI gamma-ITAM is differentially required for mast cell function in vivo. J Immunol 2004; 172(4):2374-2381. (Pubitemid 38182386)
85. Yamasaki S, Ishikawa E, Kohno M et al. The quantity and duration of FcRgamma signals determine mast cell degranulation and survival. Blood 2004; 103(8):3093-3101. (Pubitemid 38451686)
86. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80(2):179-185.
87. Werlen G, Hausmann B, Naeher D et al. Signaling life and death in the thymus: timing is everything. Science 2003; 299(5614):1859-1863. (Pubitemid 36356648)
88. Yamasaki S, Ishikawa E, Sakuma M et al. LAT and NTAL mediate immunoglobulin E-induced sustained extracellular signal-regulated kinase activation critical for mast cell survival. Mol Cell Biol 2007; 27(12):4406-4415. (Pubitemid 46906564)
89. Yamasaki S, Takase-Utsugi M, Ishikawa E et al. Selective impairment of FcepsilonRI-mediated allergic reaction in Gads-deficient mice. Int Immunol 2008; 20(10):1289-1297.
90. 2+influx-mediated histamine synthesis and IL-6 release in mast cells activated by monomeric IgE. Eur J Immunol 2005; 35(2):460-468. (Pubitemid 40331323)
91. Matsuoka K, Taya C,Kubo S et al. Establishment of antigen-specific IgE transgenic mice to study pathological and immunobiological roles of IgE in vivo. Int Immunol 1999; 11(6):987-994. (Pubitemid 29276611)
92. Oettgen HC, Martin TR, Wynshaw-Boris A et al. Active anaphylaxis in IgE-deficient mice. Nature 1994; 370(6488):367-370. (Pubitemid 24259758)
93. Gurish MF, Bryce PJ, Tao H et al. IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J Immunol 2004; 172(2):1139-1145. (Pubitemid 38113774)
94. Lantz CS, Boesiger J, Song CH et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998; 392(6671):90-93. (Pubitemid 28150595)
95. Matsuda H, Watanabe N, Geba GP et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997; 9(3):461-466. (Pubitemid 27113270)
96. Pritchard DI, Hewitt C, Moqbel R. The relationship between immunological responsiveness controlled by T-helper 2 lymphocytes and infections with parasitic helminths. Parasitology 1997; 115 Suppl:S33-44. (Pubitemid 28166132)
97. Bryce PJ, Miller ML, Miyajima I et al. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 2004; 20(4):381-392. (Pubitemid 38482117)
98. Mathias CB, Freyschmidt EJ, Caplan B et al. IgE influences the number and function ofmature mast cells, but not progenitor recruitment in allergic pulmonary inflammation. J Immunol 2009; 182(4):2416-2424.
99. Kitamura Y, Ito A. Mast cell-committed progenitors. Proc Natl Acad Sci USA 2005; 102(32):11129-11130. (Pubitemid 41153786)
100. Kitamura Y, Shimada M, Hatanaka K et al. Development of mast cells from grafted bone marrow cells in irradiated mice. Nature 1977; 268(5619):442-443.
101. Nabel G, Galli S J, Dvorak AM et al. Inducer T-lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature 1981; 291(5813):332-334. (Pubitemid 11083435)
102. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol 1994; 55:1-96.
103. Okayama Y, Kawakami T. Development, migration and survival of mast cells. Immunol Res 2006; 34(2):97-115. (Pubitemid 43997964)
104. Barrett EL, Clark MA. Tetrathionate reduction and production of hydrogen sulfide from thiosulfate. Microbiol Rev 1987; 51(2):192-205. (Pubitemid 17082510)
105. Bienenstock J, Befus AD, Pearce F et al. Mast cell heterogeneity: derivation and function, with emphasis on the intestine. J Allergy Clin Immunol 1982; 70(6):407-412. (Pubitemid 13216829)
106. McNeil HP, Austen KF, Somerville LL et al. Molecular cloning of the mouse mast cell protease-5 gene. A novel secretory granule protease expressed early in the differentiation of serosal mast cells. J Biol Chem 1991; 266(30):20316-20322. (Pubitemid 21908461)
107. Reynolds DS, Gurley DS, Austen KF et al. Cloning of the cDNA and gene of mouse mast cell protease-6. Transcription by progenitor mast cells and mast cells of the connective tissue subclass. J Biol Chem 1991; 266(6):3847-3853. (Pubitemid 21909287)
108. Reynolds DS, Stevens RL, Gurley DS et al. Isolation and molecular cloning ofmast cell carboxypeptidase A. A novel member of the carboxypeptidase gene family. J Biol Chem 1989; 264(33):20094-20099. (Pubitemid 20008130)
109. Serafin WE, Reynolds DS, RogeljS et al. Identification and molecular cloning of a novel mouse mucosal mast cell serine protease. J Biol Chem 1990; 265(1):423-429.
110. Serafin WE, Sullivan TP, Conder GA et al. Cloning of the cDNA and gene for mouse mast cell protease 4. Demonstration ofits late transcription in mast cell subclassesand analysis ofitshomologytosubclass-specific neutral proteases of the mouse and rat. J Biol Chem 1991; 266(3):1934-1941. (Pubitemid 21908388)
111. Trong HL, Newlands GF, Miller HR et al. Amino acid sequence of a mouse mucosal mast cell protease. Biochemistry 1989; 28(1):391-395. (Pubitemid 19046753)
112. Wright HV, Bailey D, Kashyap M et al. IL-3-mediated TNF production is necessary for mast cell development. J Immunol 2006; 176(4):2114-2121. (Pubitemid 43201658)
113. Kawakami Y, Yumoto K, Kawakami T. An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of Tec family kinases. Allergol Int 2007; 56(4):403-409. (Pubitemid 350306392)
114. Kawakami Y, Tomimori Y, Yumoto K et al. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med 2009; 206(6):1219-1225.
115. Kashiwakura J, Kawakami Y, Yuki K et al. Polyclonal IgE induces mast cell survival and cytokine production. Allergol Int 2009; 58(3):411-419.